| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $185.3M | $189.9M | $230.4M |
| YoY Revenue Growth % | -2.4% | -17.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$47.9M | -$23.5M | -$44.8M |
| Operating Margin % | -25.8% | -12.4% | -19.5% |
| Net Income (GAAP) | -$57.7M | -$10.1M | -$88.6M |
| EBITDA (Normalized) | -$46.3M | -$23.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$18.7M | -$20.7M | -$6.1M |
| Capital Expenditures (CapEx) | $2.0M | $691.0K | — |
| Free Cash Flow (FCF) | -$20.7M | -$21.4M | -$6.1M |
| FCF Margin % | -11.2% | -11.3% | -2.6% |
| Return on Invested Capital (ROIC %) | -45.0% | -22.6% | — |
| Cash & Short-Term Equivalents | $8.5M | $22.4M | — |
| Total Debt (Short + Long Term) | $27.9M | $0 | — |
| Total Stockholders' Equity | $49.4M | $104.8M | — |